Trademark: 90278845
Status Date
Monday, January 8, 2024
Filing Date
Monday, October 26, 2020
Published for Opposition
Tuesday, May 4, 2021
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Jan 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 8, 2024
Sou Extension 5 Granted
Dec 15, 2023
Sou Extension 5 Filed
Jan 8, 2024
Case Assigned To Intent To Use Paralegal
Dec 15, 2023
Sou Teas Extension Received
Jun 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2023
Sou Extension 4 Granted
Jun 27, 2023
Sou Extension 4 Filed
Jun 27, 2023
Sou Teas Extension Received
Dec 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 20, 2022
Sou Extension 3 Granted
Dec 20, 2022
Sou Extension 3 Filed
Dec 20, 2022
Sou Teas Extension Received
Jun 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2022
Sou Extension 2 Granted
Jun 27, 2022
Sou Extension 2 Filed
Jun 27, 2022
Sou Teas Extension Received
Dec 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 21, 2021
Sou Extension 1 Granted
Dec 21, 2021
Sou Extension 1 Filed
Dec 21, 2021
Sou Teas Extension Received
Jun 29, 2021
Noa E-Mailed - Sou Required From Applicant
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Mar 29, 2021
Approved For Pub - Principal Register
Mar 25, 2021
Assigned To Examiner
Dec 15, 2020
New Application Office Supplied Data Entered
Oct 29, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
